Cargando…

New prognostic models in metastatic renal cancer

Detalles Bibliográficos
Autores principales:	Lim, Louise, Powles, Tom
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2012
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708246/ https://www.ncbi.nlm.nih.gov/pubmed/26816702 http://dx.doi.org/10.3978/j.issn.2223-4683.2012.09.01

Ejemplares similares

Finding a New Prognostic Biomarker for Metastatic Colorectal Cancer
por: Kim, Hungdai
Publicado: (2012)

Prognostic models in papillary renal cell carcinoma
por: Attalla, Kyrollis, et al.
Publicado: (2020)

Update on the treatment of metastatic renal cell carcinoma
por: Medina López, Rafael Antonio, et al.
Publicado: (2022)

When should surgery be used to supplement systemic therapy in metastatic renal cell cancer?
por: Hardman, Morgan, et al.
Publicado: (2023)

Novel immunotherapy approaches for metastatic urothelial and renal cell carcinoma
por: Shao, Zhiying, et al.
Publicado: (2016)

Routine Bone Imaging for Metastatic Renal Cell Carcinoma: Is it Time?
por: Parikh, Mamta
Publicado: (2021)

New Prognostic and Predictive Markers in Cancer Progression
por: Costantini, Susan, et al.
Publicado: (2020)

The efficacy and safety of irinotecan cisplatin and mitomycin chemotherapy in sunitinib pre-treated metastatic clear cell renal cancer
por: Powles, Thomas, et al.
Publicado: (2008)

New insights for drug resistance in metastatic castration-resistant prostate cancer
por: Kushwaha, Prem Prakash, et al.
Publicado: (2022)

Metastatic renal carcinoma comprehensive prognostic system
por: Atzpodien, J, et al.
Publicado: (2003)

Insights into the prognostic potential of total alkaline phosphatase in metastatic castration-resistant prostate cancer treated with radium-223
por: Viani, Gustavo
Publicado: (2023)

The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer
por: Powles, T., et al.
Publicado: (2011)

Diagnostic and Prognostic Role of (18)F-Fluoroestradiol PET in Metastatic Breast Cancer: The Second Youth of an Older Theranostic Concept
por: Fiz, Francesco, et al.
Publicado: (2022)

Prognostic Factors Research in Breast Cancer Patients: New Paths
por: Susini, Tommaso, et al.
Publicado: (2022)

Metastatic Colorectal Cancer
por: Passardi, Alessandro, et al.
Publicado: (2021)

Dynamic epigenetic changes to VHL occur with sunitinib in metastatic clear cell renal cancer
por: Stewart, Grant D., et al.
Publicado: (2016)

Renal endocrinology: The new frontier
por: Sahay, Manisha, et al.
Publicado: (2012)

Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable
por: Vogl, U M, et al.
Publicado: (2006)

The tango of immunotherapy and targeted therapy in metastatic renal cell carcinoma
por: Rathi, Nityam, et al.
Publicado: (2019)

Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation‐based therapy
por: Turco, Fabio, et al.
Publicado: (2022)

New Insights into Diagnosis and Treatment of Renal Cell Carcinoma, Bladder Cancer, and Prostate Cancer
por: Chlosta, Piotr L., et al.
Publicado: (2017)

Current status and future directions of ovarian cancer prognostic models
por: Kobayashi, Yusuke, et al.
Publicado: (2021)

New Prognostic Biomarkers in Metastatic Castration-Resistant Prostate Cancer
por: Conteduca, Vincenza, et al.
Publicado: (2021)

The management of low-stage non-seminomatous germ cell tumors
por: Lim, Louise, et al.
Publicado: (2012)

Retrospective comparison of the different immune combinations in metastatic renal cell carcinoma
por: Grünwald, Viktor, et al.
Publicado: (2020)

Gene expression profiles and treatments for metastatic renal cell carcinoma: What does still need to be defined?
por: Giunta, Emilio F., et al.
Publicado: (2022)

Evaluation of microvascular invasion as a prognostic factor in the progression of non-metastatic renal cancer
por: Bengió, Rubén G., et al.
Publicado: (2018)

Preventing metastatic emergence of breast cancer
por: Wells, Alan, et al.
Publicado: (2021)

Seeking new prognostic and predictive factors in patients with metastatic renal cell carcinoma – apoptosis-regulating factors
por: Młot, Beata, et al.
Publicado: (2012)

Seeking new prognostic and predictive factors in patients with metastatic renal cell carcinoma – hypoxia-induced factors
por: Młot, Beata, et al.
Publicado: (2012)

Prognostic value and model construction of preoperative inflammatory markers in patients with metastatic renal cell carcinoma
por: Wang, Jichen, et al.
Publicado: (2023)

Targeted treatment of metastatic castration-resistant prostate cancer with sipuleucel-T immunotherapy
por: Mulders, Peter F., et al.
Publicado: (2015)

VENUSS rising for papillary renal cell carcinoma prognostication?
por: Buchler, Tomas
Publicado: (2020)

Prognostic Factors after Surgery for Salivary Gland Cancer; What Is New, and What Is Next?
por: Camaioni, Angelo, et al.
Publicado: (2022)

Gene Expression and DNA Methylation as Prognostic Markers in Metastatic Castration-Resistant Prostate Cancer: Analysis of Circulating Tumor Cells and Paired Plasma-Derived Exosomes
por: Hussein, Mohamed Ali, et al.
Publicado: (2023)

Improving the prognostic accuracy in renal cell carcinoma with venous thrombus with novel predictive nomograms
por: Zapała, Łukasz, et al.
Publicado: (2022)

Local therapy in patients with metastatic prostate cancer: a new standard of care?
por: Harper, Benjamin, et al.
Publicado: (2019)

Prognostic factors for renal function deterioration during palliative first-line chemotherapy for metastatic colorectal cancer: a retrospective study
por: Lim, Ah Reum, et al.
Publicado: (2022)

Treatment of metastatic prostate cancer after STAMPEDE
por: Wolf, Philipp
Publicado: (2017)

Recent Scientific Developments in Metastatic Prostate Cancer
por: Heidegger, Isabel
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tg6ptk0355k7ntie990u02vo8l